NCT06774950Not yet recruiting
Value-based Care in Type 2 Diabetes (Enhancing T2D Care)
Améliorer La Prise En Soins Et La Qualité De Vie Des Patients Diabétiques De Type 2 (Alliance DT2)
Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to obtain a better glycemic index score (decrease) by improving the care and quality of life of type 2 diabetic patients for a possible remission of diabetes. This will be achieved through an intervention that includes a strategy for training primary care physicians and other healthcare professionals in patient therapeutic education (TPE), as well as group and/or individual TPE-related activities/tools made available to patients, funded and encouraged for individualized planning. Intervention follow-up will be carried out by means of quality-of-life questionnaires for patients who have undergone the new method, compared with patients who have received the usual care.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 154 (estimated)
- First submitted
- 10 Dec 2024
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Aug 2025
- Lead sponsor
- Réseau de soins Delta
- Diseases
- Type 2 diabetes
- NCT number
- NCT06774950
What you commit to
- Study type: Interventional
- Planned participants: 154
- From 1 Mar 2025 to the primary completion date, 1 Aug 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Significant comorbidities linked to worsening diabetes (such as renal failure, previous myocardial infarction, retinopathy, signs or symptoms of severe diabetic neuropathy or diabetic foot ulcers), severe osteoarthritis or as judged by the attending physician.
Other
- Pregnant or breast-feeding women
- Persons who are unable to give signed informed consent
Who the study is looking for
- Patients with newly diagnosed type 2 diabetes (less than 10 years)
- Age (between 40 and 65)
Age in the registry: 40 years to 65 years · Sex: All · Does not accept healthy volunteers
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.